4//SEC Filing
Corbus Pharmaceuticals Holdings, Inc. 4
Accession 0001209191-17-017506
$CRBPCIK 0001595097operating
Filed
Mar 2, 7:00 PM ET
Accepted
Mar 3, 4:20 PM ET
Size
5.6 KB
Accession
0001209191-17-017506
Insider Transaction Report
Form 4
White Barbara
Chief Medical Officer
Transactions
- Award
Stock Option(right to buy)
2017-03-01+115,000→ 115,000 totalExercise: $9.05Exp: 2027-03-01→ Common Stock (115,000 underlying)
Footnotes (1)
- [F1]The option award was made in accordance with the terms of the issuer's 2014 Equity Compensation Plan. 25% of the option vests on March 1, 2018, with the remaining 75% of the option vesting in equal monthly installments over a period of 36 months commencing on April 1, 2018.
Documents
Issuer
Corbus Pharmaceuticals Holdings, Inc.
CIK 0001595097
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001595097
Filing Metadata
- Form type
- 4
- Filed
- Mar 2, 7:00 PM ET
- Accepted
- Mar 3, 4:20 PM ET
- Size
- 5.6 KB